                         SEQUENCE LISTING

<110>  UNIVERSITY OF UTAH RESEARCH FOUNDATION
 
<120>  METHODS FOR PRODUCING RIBOSOMALLY SYNTHESIZED AND 
       POSTTRANSLATIONALLY MODIFIED PEPTIDES

<130>  026389-9175-WO00

<140>  PCT/US2016/057105
<141>  2016-10-14

<150>  62/241,583
<151>  2015-10-14

<160>  11    

<170>  PatentIn version 3.5

<210>  1
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  1

Gly Val Asp Ala Ser 
1               5   


<210>  2
<211>  3
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  2

Ser Tyr Asp 
1           


<210>  3
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  3

Ser Tyr Asp Asp 
1               


<210>  4
<211>  26
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  Xaa
<222>  (8)..(8)
<223>  Thiazoline

<220>
<221>  Xaa
<222>  (22)..(22)
<223>  Thiazoline

<400>  4

Thr Leu Pro Val Pro Thr Leu Xaa Ser Tyr Asp Gly Val Asp Ala Ser 
1               5                   10                  15      


Thr Val Pro Thr Leu Xaa Ser Tyr Asp Asp 
            20                  25      


<210>  5
<211>  26
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  5

Thr Leu Pro Val Pro Thr Leu Cys Ser Tyr Asp Gly Val Asp Ala Ser 
1               5                   10                  15      


Thr Val Pro Thr Leu Cys Ser Tyr Asp Asp 
            20                  25      


<210>  6
<211>  16
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  Xaa
<222>  (8)..(8)
<223>  Thiazoline

<400>  6

Thr Leu Pro Val Pro Thr Leu Xaa Ser Tyr Asp Gly Val Asp Ala Ser 
1               5                   10                  15      


<210>  7
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  Xaa
<222>  (6)..(6)
<223>  Thiazoline

<400>  7

Thr Val Pro Thr Leu Xaa Ser Tyr Asp Asp 
1               5                   10  


<210>  8
<211>  79
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Primer

<400>  8
agtgtacagg gccccccctc gagggtatcg ataagcttga tatcgaattc ctgcagtagg       60

aggaattaac ccatatgtc                                                    79


<210>  9
<211>  78
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Primer

<400>  9
gatgagctcc accgcggtgg cggccgctct agaactagtg gatcccccgg gtaccatgga       60

catatgggtt aattcctc                                                     78


<210>  10
<211>  75
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  10

Met Asn Lys Lys Asn Ile Leu Pro Gln Leu Gly Gln Pro Val Ile Arg 
1               5                   10                  15      


Leu Thr Gly Gly Ser His His His His His His Ser Gly Ala Gly Gln 
            20                  25                  30          


Leu Ser Ser Gln Leu Ala Glu Leu Ser Glu Glu Ala Leu Gly Gly Val 
        35                  40                  45              


Asp Ala Ser Thr Val Pro Thr Leu Cys Ser Tyr Asp Gly Val Asp Ala 
    50                  55                  60                  


Ser Thr Val Pro Thr Leu Cys Ser Tyr Asp Asp 
65                  70                  75  


<210>  11
<211>  77
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  11

Met Gly Ser Ser His His His His His His Ser Gly Gly Met Asn Lys 
1               5                   10                  15      


Lys Asn Ile Leu Pro Gln Leu Gly Gln Pro Val Ile Arg Leu Thr Ala 
            20                  25                  30          


Gly Gln Leu Ser Ser Gln Leu Ala Glu Leu Ser Glu Glu Ala Leu Gly 
        35                  40                  45              


Gly Val Asp Ala Ser Thr Val Pro Thr Leu Cys Ser Tyr Asp Gly Val 
    50                  55                  60                  


Asp Ala Ser Thr Val Pro Thr Leu Cys Ser Tyr Asp Asp 
65                  70                  75          


